Floatz logo

ABOBOTULINUMTOXINA

Compartment Syndrome of Leg

Emory Universityprotein_peptidePhase 4 / ApprovedActive
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Compartment Syndrome of Leg cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

ABOBOTULINUMTOXINA is also rated in:

Spasticity, MuscleDormant
CCC
Indicative ·
51 / 100
View asset →
Lower Back PainDormant
CC
Indicative ·
47 / 100
View asset →
PainDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →